Understanding glioblastoma biomarkers: knocking a mountain with a hammer
Gliomas are the most frequent and deadly form of human primary brain tumors. Among them, the most common and aggressive type is the high-grade glioblastoma multiforme (GBM), which rapidly grows and renders patients a very poor prognosis. Meanwhile, cancer stem cells (CSCs) have been determined in gl...
Main Authors: | Mesrati, Malak Hassn, Behrooz, Amir Barzegar, Abuhamad, Asmaa Y., Amir Hamzah, Amir Syahir |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2020
|
Online Access: | http://psasir.upm.edu.my/id/eprint/36976/1/36976.pdf |
Similar Items
-
Could we address the interplay between CD133, Wnt/β-Catenin, and TERT signaling pathways as a potential target for Glioblastoma therapy?
by: Behrooz, Amir Barzegar, et al.
Published: (2021) -
Nanotechnology-based combinatorial anti-glioblastoma therapies: moving from terminal to treatable
by: Barzegar Behrooz, Amir, et al.
Published: (2022) -
CD44: A multifunctional mediator of cancer progression
by: Malak Hassn, Mesrati, et al.
Published: (2021) -
Hyaluronic acid/chitosan-coated poly (lactic-co-glycolic acid) nanoparticles to deliver single and co-loaded paclitaxel and temozolomide for CD44+oral cancer cells
by: Mesrati, Malak Hassn, et al.
Published: (2023) -
Hyaluronic acid/chitosan-coated poly (lactic-co-glycolic acid) nanoparticles to deliver paclitaxel and temozolomide for oral cancer cells
by: Hassn Ali, Mesrati Malak
Published: (2022)